Skip to main content
. 2021 Mar 9;15:1101–1110. doi: 10.2147/DDDT.S296197

Table 4.

Summary of Pharmacokinetic Parameters for Multiple Ascending Dose (MAD) of Benfotiamine

Analytes Parameters MAD
150 mg (n=12) 300 mg (n=12) 600 mg (n=12)
Day 1 Day 10 Day 1 Day 10 Day 1 Day 10
TM AUC0-t, ng·h/mL 1639.8 (322.8) 3795.1 (700.4) 4902.9 (780.8) 11,081.3 (1237.2) 13,493.8 (2185.3) 31,855.0 (4967.3)
Cmax, ng/mL 276 (57) 439 (84) 624 (104) 1089 (131) 1485 (208) 2783 (470)
Tmax, h 1.5 (0.5–2.5) 1.5 (0.5–2.0) 1.5 (1.0–3.5) 1.8 (0.5–4.0) 2.0 (1.0–3.0) 2.0 (1.5–3.0)
t1/2, h 37.2 (21.0) 36.48 (8.1) 29.0 (8.9) 25.97 (4.62) 16.8 (3.6) 16.46 (3.07)
CL/F, L/h 90.1 (18.8) 37.57 (6.92) 61.2 (9.5) 26.54 (3.02) 45.2 (7.2) 18.97 (2.95)
Vd/F, L 4522 (2119) 1969 (537) 2609 (1052) 1008 (275) 1112 (356) 455 (127)
AUC0-τ, ng·h/mL 1334.4 (245.3) 2614.0 (476.6) 3694.8 (551.8) 7481.91 (763.0) 9428.3 (1392.1) 19,824.0 (2968.6)
Cmin, ng/mL 107 (28) 363 (51) 1104 (195)
Cav, ng/mL 218 (40) 623 (64) 1652 (247)
Rac 1.96 (0.16) 2.05 (0.22) 2.11 (0.16)
Rac, Cmax 1.60 (0.15) 1.78 (0.28) 1.88 (0.24)
TDP AUC0-t, ng·h/mL 2198.9 (640.5) 4009.8 (1089.1) 2984.0 (681.9) 5141.4 (1342.2) 3588.6 (1356.3) 5617.7 (1958.9)
Cmax, ng/mL 68 (19) 111 (31) 79 (20) 126 (35) 77 (30) 126 (40)
Tmax, h 8.0 (6.0–12.0) 1.5 (0.0–6.0) 12.0 (8.0–12.0) 1.8 (0.0–12.0) 12.0 (6.0–36.0) 2.0 (0.0–12.0)
t1/2, h 67.4 (61.1) 51.2 (26.4) 34.3 (17.9) 37.4 (10.5) 28.7 (5.0) 41.7 (16.1)
CL/F, L/h 44.0 (15.9) 27.7 (9.2) 83.9 (27.6) 46.6 (15.2) 150.0 (54.0) 80.9 (21.6)
Vd/F, L 3396 (1304) 1950 (1099) 3809 (1261) 2446 (804) 6129 (2265) 4777 (2117)
AUC0-τ, ng·h/mL 620.8 (206.9) 1147.0 (333.3) 654.4 (134.5) 1338.3 (404.5) 640.2 (232.8) 1230.8 (390.1)
Cmin, ng/mL 101 (32) 113 (34) 106 (38)
Cav, ng/mL 96 (28) 112 (34) 103 (33)
Rac 1.88 (0.19) 2.03 (0.32) 1.97 (0.25)
Rac, Cmax 1.62 (0.15) 1.59 (0.20) 1.69 (0.24)